Immunotherapy of cancer. An innovative treatment comes of age (2016) | ПРЕЦИЗИОННАЯ ОНКОЛОГИЯ

Immunotherapy of cancer. An innovative treatment comes of age (2016)

Immunotherapy of cancer. An innovative treatment comes of age (2016) - ОБЛОЖКА

Yoshiyuki Yamaguchi (Editor). Immunotherapy of cancer. An innovative treatment comes of ageSpringer (2016)

ISBN 978-4-431-55030-3

ISBN 978-4-431-55031-0 (eBook)


Part I. Overview, history, classification

  • Overview of current cancer immunotherapy

Part II. BRMs and crude agents

  • Bacterial preparations
  • Polysaccharides
  • BCG

Part III. Adoptive cell therapy

  • αβ-T Cells
  • NKT cell-based immunotherapy
  • Natural killer cells
  • γδ T cell-based cancer immunotherapy
  • Genetically engineered T cells

Part IV. Vaccine therapy

  • Peptide vaccine
  • Personalized peptide vaccine
  • WT1 peptide vaccine for the treatment of malignancies: its development, recent progress, and future perspectives
  • Protein vaccine
  • Dendritic cell-based vaccine for cancer

Part V. Immunoadjuvants

  • CpG motif
  • Pattern recognition by dendritic cells and its application to vaccine adjuvant for antitumor immunotherapy
  • Novel adjuvants

Part VI. Immunocheckpoints

  • Anti-CTLA-4 Ab
  • Anti-PD-1 and anti-PD-L1 mAbs
  • Novel targets of immune inhibitory and stimulatory co-signals

Part VII. Regulation of immunosuppression

  • Regulatory T cells
  • MDSC: myeloid-derived suppressor cells

Part VIII. Immune-related response criteria and guidance for clinical trials

  • Immune-related response criteria and guidance for clinical trials

Part IX. Personalized immunotherapy

  • Personalized cancer immunotherapy: immune biomarkers and combination immunotherapy

Download:


Текст защищен. Пожалуйста, введите логин и паспорт или зарегистрируйтесь. Enter your username and password to gain access to this review.
:
:


 

0